Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 187

Sort by

Sort Order Select

Journal Articles

Single-cell sequencing of bone marrow cells and peripheral mononuclear cells reveals immune features of paraneoplastic pemphigus in a FL patient

Rong Wei, Shenmiao Yang, Jin Lu, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 7114.

https://doi.org/10.1182/blood-2025-7114

Published: 2025

Journal Articles

All-trans retinoic acid for refractory cancer therapy-induced thrombocytopenia: A new option beyond TPO-ras?

Linya Wang, Haitao Gao, Qiang Fu, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Feifei Tang

Blood (2025) 146 (Supplement 1): 1265.

https://doi.org/10.1182/blood-2025-1265

Published: 2025

Journal Articles

Clinical profiling and outcomes of ischemic stroke patients with immune thrombocytopenia: A multicenter real-world study

Liqin Cao, Jin Wu, Fan Zhou, Dengju Li, LiLi Ji, ZhuRuoHan Yu, Yuping Gong, Kaiteng Cai, Guoyang Zhuang, YanYan Xie, Xiaolu Zhu, Qiu-Sha Huang, Hai-Xia Fu, ZePing Zhou, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1264.

https://doi.org/10.1182/blood-2025-1264

Published: 2025

Journal Articles

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Peng Zhao, Jing-Li Han, Hai-Xia Fu, Zhuo-Yu An, Yue Jin, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1243.

https://doi.org/10.1182/blood-2025-1243

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Meng Lv, Hao Jiang, Yuhua Li, Yicheng Zhang, Jie Jin, Hongsheng Zhou, Kailin Xu, Mingfeng Zhao, Xin Du, Kai Hu, Jun Hu, Jinghua Zhao, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1563.

https://doi.org/10.1182/blood-2025-1563

Published: 2025

Journal Articles

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

Jiaxin Zhang, Jin Wu, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Feng-Rong Wang, Yuqian Sun, Meng Lv, Yuhong Chen, Xiang-Yu Zhao, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6056.

https://doi.org/10.1182/blood-2025-6056

Published: 2025

Journal Articles

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Qiu-Sha Huang, Qing-Yuan Qu, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 197.

https://doi.org/10.1182/blood-2025-197

Published: 2025

Journal Articles

SOCS1 in graft CD8+ T cells ameliorates intestinal aGVHD by modulating chemokine-driven monocyte-to-M1 macrophage polarization

Xiaojun Huang, Huidong Guo, Zhigui Wu

Blood (2025) 146 (Supplement 1): 6003.

https://doi.org/10.1182/blood-2025-6003

Published: 2025

Journal Articles

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Feng Zhang, Suo Pan, Guanhua Hu, Lu Bai, Yingxi Zuo, Zhengli Xu, Lanping Xu, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Yifei CHENG

Blood (2025) 146 (Supplement 1): 5977.

https://doi.org/10.1182/blood-2025-5977

Published: 2025

Journal Articles

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

Yi-Han Yang, Meng Lv, Jia Chen, Jing Liu, Xiaohui Zhang, Lanping Xu, Xi Zhang, Daihong Liu, Depei Wu, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1706.

https://doi.org/10.1182/blood-2025-1706

Published: 2025

Journal Articles

Safety and efficacy of venetoclax plus CAG (cytarabine, aclarubicin, G-CSF) regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective single-arm phase II study

Wen-Jing Yu, Wen-Bing Duan, Qi Chen, Xuying Pei, Jinsong JIA, Jing Wang, Xiaolu Zhu, Xiaosu Zhao, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 1680.

https://doi.org/10.1182/blood-2025-1680

Published: 2025

Journal Articles

Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial

Xiaolu Zhu, Zhao Ting, Wen-Bing Duan, Qi Chen, Jing Liu, Wen-Jing Yu, Xiaosu Zhao, Ya-Zhen Qin, Hong-Xia Shi, Ying-Jun Chang, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 1671.

https://doi.org/10.1182/blood-2025-1671

Published: 2025

Journal Articles

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

Xiaohui Zhang, Lixin Wu, Ping Zhang, Jia Feng, Xiaojun Huang, Hongyu Zhang

Blood (2025) 146 (Supplement 1): 5054.

https://doi.org/10.1182/blood-2025-5054

Published: 2025

Journal Articles

CD123-targeted radiotheranostics of Acute Myeloid Leukemia with 89Zr/177Lu-labeled pivekimab

Qichen Hu, Yijing Zhao, Siqi Zhang, Kun Wang, Xin Gao, Dengfu Wu, Jieting Shen, Qingshuang Lu, Xuekai Song, Quan Zuo, Robert Gale, Rui Wang, Xiaojun Huang, Kuan Hu

Blood (2025) 146 (Supplement 1): 5052.

https://doi.org/10.1182/blood-2025-5052

Published: 2025

Journal Articles

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

Chen Zhao, Yuanyuan Zhang, Hai-Xia Fu, Xiao-Dong Mo, Zhi-Dong Wang, Fengrong Wang, Yuhong Chen, Yuqian Sun, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6015.

https://doi.org/10.1182/blood-2025-6015

Published: 2025

Journal Articles

FLT3-ITD drives poor prognosis in NPM1 mutated AML via BCAT1-dependent epigenetic regulation

Kainan Zhang, Xiaohang Ma, Xiaoxuan Lu, Guorui Ruan, Fangfang Wei, Hao Jiang, Xiaojun Huang, Xiaosu Zhao

Blood (2025) 146 (Supplement 1): 5003.

https://doi.org/10.1182/blood-2025-5003

Published: 2025

Journal Articles

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

Juanjuan Li, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Xiang-Yu Zhao, Meng Lv, YuHong Chen, Yu Wang, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2025-3126

Published: 2025

Journal Articles

A novel CD20-conjugated γδ T cell therapy via unnatural sugar-mediated chemical modification for the treatment of EBV-PTLD

Xuying Pei, Haichuan Zhu, Bo Cheng, Zhifan Zhao, Peng Zhou, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 2353.

https://doi.org/10.1182/blood-2025-2353

Published: 2025

Journal Articles

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Jing-Li Han, Meng-Yu Xiao, Jian-Ying Zhou, Ting Wang, Xiaolu Zhu, Hai-Xia Fu, Qian Jiang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2025-3235

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Single-cell sequencing of bone marrow cells and peripheral mononuclear cells reveals immune features of paraneoplastic pemphigus in a FL patient

All-trans retinoic acid for refractory cancer therapy-induced thrombocytopenia: A new option beyond TPO-ras?

Clinical profiling and outcomes of ischemic stroke patients with immune thrombocytopenia: A multicenter real-world study

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Kte-X19 in relapsed or refractory adult B-cell acute lymphoblastic leukemia in the Chinese population: 6-month analysis of a phase II multicenter trial

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

SOCS1 in graft CD8+ T cells ameliorates intestinal aGVHD by modulating chemokine-driven monocyte-to-M1 macrophage polarization

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

Safety and efficacy of venetoclax plus CAG (cytarabine, aclarubicin, G-CSF) regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective single-arm phase II study

Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

CD123-targeted radiotheranostics of Acute Myeloid Leukemia with 89Zr/177Lu-labeled pivekimab

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

FLT3-ITD drives poor prognosis in NPM1 mutated AML via BCAT1-dependent epigenetic regulation

Clinical characteristics and outcomes of cerebral venous sinus thrombosis in hematologic malignancy patients pre- and post-hematopoietic stem cell transplantation: A single-center retrospective study in China

A novel CD20-conjugated γδ T cell therapy via unnatural sugar-mediated chemical modification for the treatment of EBV-PTLD

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only